INTERNATIONAL PATENT: POSEIDA THERAPEUTICS, INC. FILES APPLICATION FOR "CHIMERIC TUMOR NECROSIS FACTOR RECEPTOR 1 COMPOSITIONS AND METHODS OF USE THEREOF"

GENEVA, Oct. 28 -- POSEIDA THERAPEUTICS, INC. (9390 Towne Centre Drive, Suite 200San Diego, California 92121) filed a patent application (PCT/US2025/024779) for "CHIMERIC TUMOR NECROSIS FACTOR RECEPTOR 1 COMPOSITIONS AND METHODS OF USE THEREOF" on Apr 15, 2025. With publication no. WO/2025/221796, the details related to the patent application was published on Oct 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MADISON, Blair B. (c/o Poseida Therapeutics, Inc.9390 Towne Centre Drive, Suite 200San Diego, California 92121)

Abstract: Disclosed are compositions comprising dominant negative c...